News + Filings Transactions
|
DOUGHERTY MICHAEL R
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/03/2022 | Aceragen, Inc. | IDRA | Grant | Common Stock | 58.5k | $0.37 | $21.9k | | 10/03/2022 |
07/01/2022 | Aceragen, Inc. | IDRA | Grant | Common Stock | 50.1k | $0.44 | $21.9k | | 07/01/2022 |
06/23/2022 | Aceragen, Inc. | IDRA | Grant | | 26k | $0.46 | $11.9k | | 06/23/2022 |
06/09/2022 | TREVENA INC | TRVN | Grant | Stock Option (Right to Buy) | 100k | $0.43 | $43k | | 06/09/2022 |
04/01/2022 | Aceragen, Inc. | IDRA | Grant | Common Stock | 41.2k | $0.54 | $22k | | 04/01/2022 |
02/04/2022 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock Option (Right to Buy) | 12.4k | $10.40 | $128.7k | | 02/04/2022 |
02/04/2022 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Common Stock | 2.8k | $0.00 | $0 | | 02/04/2022 |
01/03/2022 | Aceragen, Inc. | IDRA | Grant | Common Stock | 37.1k | $0.59 | $21.9k | | 01/03/2022 |
10/04/2021 | Aceragen, Inc. | IDRA | Grant | Common Stock | 21.2k | $1.03 | $21.9k | | 10/04/2021 |
06/08/2021 | Aceragen, Inc. | IDRA | Grant | | 26k | $1.31 | $34.1k | | 06/08/2021 |
06/01/2021 | Aceragen, Inc. | IDRA | Purchase | Common Stock | 85k | $1.19 | $101.2k | | 06/01/2021 |
05/28/2021 | TREVENA INC | TRVN | Grant | Stock Option (Right to Buy) | 68.6k | $1.74 | $119.3k | | 05/28/2021 |
01/15/2021 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock option (right to buy) | 16.5k | $12.60 | $207.9k | | 01/15/2021 |
10/01/2020 | Aceragen, Inc. | IDRA | Grant | Common Stock | 5.7k | $2.25 | $12.9k | | 10/01/2020 |
07/01/2020 | Aceragen, Inc. | IDRA | Grant | Common Stock | 7.2k | $1.79 | $12.9k | | 07/01/2020 |
05/13/2020 | TREVENA INC | TRVN | Grant | Stock Option (Right to Buy) | 64.1k | $1.05 | $67.3k | | 05/13/2020 |
05/12/2020 | Aceragen, Inc. | IDRA | Grant | | 11.5k | $1.97 | $22.7k | | 05/12/2020 |
04/01/2020 | Aceragen, Inc. | IDRA | Grant | Common Stock | 10.1k | $1.28 | $12.9k | | 04/01/2020 |
01/08/2020 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock option (right to buy) | 100k | $2.07 | $207k | | 01/08/2020 |
01/02/2020 | Aceragen, Inc. | IDRA | Grant | Common Stock | 7k | $1.85 | $13k | | 01/02/2020 |
10/01/2019 | Aceragen, Inc. | IDRA | Grant | Common Stock | 4.1k | $2.67 | $11k | | 10/01/2019 |
06/04/2019 | Aceragen, Inc. | IDRA | Grant | | 11.5k | $2.57 | $29.6k | | 06/04/2019 |
05/16/2019 | TREVENA INC | TRVN | Grant | Stock Option (Right to Buy) | 30k | $1.34 | $40.2k | | 05/16/2019 |
04/08/2019 | Aceragen, Inc. | IDRA | Grant | Stock Option (Right to Buy) | 23k | $2.66 | $61.2k | | 04/08/2019 |
02/26/2019 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock option (right to buy) | 35k | $3.96 | $138.6k | | 02/26/2019 |
07/31/2018 | Foundation Medicine, Inc. | FMI | Other | Common Stock | 12.1k | $137.00 | $1.7M | | 07/31/2018 |
07/31/2018 | Foundation Medicine, Inc. | FMI | Other (disposition) | Common Stock | 12.7k | $137.00 | $1.7M | | 07/31/2018 |
05/16/2018 | TREVENA INC | TRVN | Grant | Stock Option (Right to Buy) | 30k | $1.84 | $55.2k | | 05/16/2018 |
12/06/2017 | MARINUS PHARMACEUTICALS, INC. | MRNS | Grant | Stock option (right to buy) | 35k | $6.19 | $216.6k | | 12/06/2017 |
06/20/2017 | Foundation Medicine, Inc. | FMI | Grant | Common Stock | 5.8k | $40.05 | $231.7k | | 06/20/2017 |
05/18/2017 | Vaxart, Inc. | VXRT | Grant | Stock Option (Right to Buy) | 20k | $0.49 | $9.8k | | 05/18/2017 |
05/17/2017 | TREVENA INC | TRVN | Grant | Stock Option (Right to Buy) | 15k | $3.08 | $46.2k | | 05/17/2017 |
01/03/2017 | CEMPRA, INC. | MLNT | Grant | Stock Option (Right to Buy) | 15k | $3.00 | $45k | | 01/03/2017 |
10/26/2016 | Foundation Medicine, Inc. | FMI | Grant | Common Stock | 19k | $23.55 | $447.5k | | 10/26/2016 |
07/12/2016 | Celator Pharmaceuticals Inc | CPXX | Disposition | Common Stock | 20k | $30.25 | $605k | | 07/12/2016 |
|
|